Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to TemozolomideZeinab Sharifi, Siham Sabri, Bassam Abdulkarim et al.|Clinical Cancer Research|2019Cited by 58
Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 statusMariia Patyka, Siham Sabri, Zeinab Sharifi et al.|Oncotarget|2016Cited by 40
Target Modulation by a Kinase Inhibitor Engineered to Induce a Tandem Blockade of the Epidermal Growth Factor Receptor (EGFR) and c-Src: The Concept of Type III Combi-TargetingSuman Rao, Bertrand J. Jean‐Claude|PLoS ONE|2015Cited by 25
Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced TargetingSuman Rao, Bertrand J. Jean‐Claude|International Journal of Molecular Sciences|2021Cited by 2
Supplementary Figure S4 from Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to TemozolomideZeinab Sharifi, Siham Sabri, Bassam Abdulkarim et al.|Unknown|2023Cited by 0